Trademark: 97612170
Word
IVENIX INFUSION SYSTEM
Status Date
Monday, May 20, 2024
Filing Date
Thursday, September 29, 2022
Published for Opposition
Tuesday, October 17, 2023
10 Medical devices for dosage, measuring and monitoring, namely, drug delivery devices in the nature of infusion pumps for delivering medications and fluids to patients; medical devices for dosage, measuring and monitoring, namely, drug delivery devices in the nature of drug delivery infusion systems comprised of pumps, computer hardware and software, and disposable tubing and related parts and accessories, for delivery of medications and fluids to patients
The mark consists of the stylized wording "IVENIX INFUSION SYSTEM".
Color is not claimed as a feature of the mark.
"INFUSION SYSTEM"
Oct 3, 2022
New Application Entered
Oct 17, 2022
New Application Office Supplied Data Entered
Jul 14, 2023
Assigned To Examiner
Jul 17, 2023
Non-Final Action Written
Jul 17, 2023
Non-Final Action E-Mailed
Jul 17, 2023
Notification Of Non-Final Action E-Mailed
Aug 16, 2023
Teas Response To Office Action Received
Aug 16, 2023
Correspondence Received In Law Office
Aug 16, 2023
Teas/Email Correspondence Entered
Aug 17, 2023
Approved For Pub - Principal Register
Aug 29, 2023
Withdrawn From Pub - Og Review Query
Sep 13, 2023
Previous Allowance Count Withdrawn
Sep 14, 2023
Examiners Amendment -Written
Sep 14, 2023
Examiners Amendment E-Mailed
Sep 14, 2023
Notification Of Examiners Amendment E-Mailed
Sep 14, 2023
Examiner's Amendment Entered
Sep 14, 2023
Approved For Pub - Principal Register
Oct 17, 2023
Published For Opposition
Oct 17, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 12, 2023
Noa E-Mailed - Sou Required From Applicant
Sep 27, 2023
Notification Of Notice Of Publication E-Mailed
May 20, 2024
Teas Statement Of Use Received
May 20, 2024
Sou Extension 1 Filed
May 20, 2024
Sou Extension 1 Granted
May 20, 2024
Sou Teas Extension Received
May 21, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
